Glycated hemoglobin A 1c as screening for diabetes mellitus in HIV-infected individuals

AIDS Patient Care and STDs

Volumn 26, Issue 4, 2012, Pages 197-201

  Eckhardt, Benjamin J ^a,b,c   Holzman, Robert S ^a,c   Kwan, Candice K ^a,c   Baghdadi, Jonathan ^a,c,d   Aberg, Judith A ^a,c  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATAZANAVIR; DARUNAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; ETRAVIRINE; FOSAMPRENAVIR; GLUCOSE; HEMOGLOBIN A1C; INDINAVIR; LAMIVUDINE; LOPINAVIR; MARAVIROC; NELFINAVIR; NEVIRAPINE; RALTEGRAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CELL VOLUME; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FASTING BLOOD GLUCOSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ANTI-HIV AGENTS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 84859297740     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2011.0379     Document Type: Article

References (18)

1. Brown T, Cole S, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study. Arch Intern Med 2005;165:1179- 1184. (Pubitemid 40720744)
2. Tien P, Schneider M, Cole, et al. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. AIDS 2007;21:1739-1745. (Pubitemid 47237561)
3. Samaras K. Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. J Acquir Immune Defic Syndr 2009;50:499-505.
4. Guaraldi G, Orlando G, Zona, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011;53:1120- 1126.
5. Lundgren JD, Battegay M, Behrens G, et al. European AIDS clinical society (EASC) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med 2008;9: 72-81. (Pubitemid 351232645)
6. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine association of the Infectious Disease Society of America. Clin Infect Dis 2009;49:651-681.
7. International Expert Committee. International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334.
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011;34:S62-S69.
9. Polgreen P, Putz D, Stapleton JT. Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus. Clin Infect Dis 2003;37:e53-56.
10. Diop ME, Bastard JP, Meunier N, et al. Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients. AIDS Res Hum Retroviruses 2006;22:1242-1247. (Pubitemid 46095241)
11. Kim P, Woods C, Georgoff P, et al. A1C underestimates glycemia in HIV infection. Diabetes Care 2009;32:1591-1593.
12. Glesby M, Hoover D, Shi Q, et al. Glycated haemoglobin in diabetic women with and without HIV infection: Data from the Women's Interagency HIV Study. Antivir Ther 2010;15: 571-577.
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
14. R Development Core Team (2011). R: A language and environment for statistical computing. Vienna, Austrai: R Foundation for Statistical Computing. www.R-project.org/(Last accessed January 3, 2012).
15. Buell C, Kerman D, Davidson M. Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 2007;30:2233-2235. (Pubitemid 47359021)
16. Steele RH, Keogh GL, Quin J, Fernando SL, Stojkova V. Mean cell volume (MCV) changes in HIV-positive patients taking nucleoside reverse transcriptase inhibitors (NRTIs): A surrogate marker for adherence. Int J STD AIDS 2002;13: 748-754. (Pubitemid 35222008)
17. Geene D, Sudre P, Anwar D, et al. Causes of macrocytosis in HIV-infected Patients not treated with zidovudine: Swiss HIV Cohort Study. J Infect 2000;40:160-163. (Pubitemid 30312555)
18. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: A cross-sectional analysis of 2 studies. Ann Intern Med 2010; 152:770-777.